Additionally, CXCR6 expression was significantly elevated on cytotoxic T lymphocytes (CTLs) (p < 0.0001) but showed no significant difference on CD4<sup>+</sup> T cells between PD patients and controls (p > 0.05). This evidence concerns the gene CD4 and Parkinson disease.